Home Bratislava Medical Journal 2018 Bratislava Medical Journal Vol.119, No.4, p.240-244, 2018

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.119, No.4, p.240-244, 2018

Title: The effect of intrathecal sufentanil preconditioning against myocardial ischemia-reperfusion injury
Author: Y. Tire, G. Sarkilar, H. Esen, R. Onoglu, S. T. Uzun
Abstract: OBJECTIVES: We aimed to investigate the cardioprotective effect and hemodynamic response of intrathecally administered sufentanil on myocardial IR injury.
BACKGROUND: Sufentanil, mu opioid receptor agonist, intravenously administered during clinical and experimental studies, has been shown to have a cardioprotective effect on myocardial ischemia–reperfusion injury.
METHODS: Thirty-two New Zealand type rabbits, which were anesthetized, were divided into four equal groups: sham, ischemia–reperfusion, sufentanil and ischemia–reperfusion+sufentanil. Sufentanil was administered intrathecally prior to ischemia. Hemodynamic parameters were monitored by electrocardiography and invasive arterial blood pressure measurements. In the ischemia–reperfusion groups, the degree of myocardial infarct was determined as the ratio of ischemic region to the risk area by a 1 % 2,3,5-triphenyl tetrazolium chloride staining.
RESULTS: The mean infarct size in the ischemia–reperfusion group was 47.5 ± 7.0 %, whereas that of the ischemia–reperfusion+sufentanil group was found to be 34.2 ± 4.7 %, indicating a statistically significant difference (p = 0.002). The heart rate was different between the ischemia–reperfusion and the sufentanil groups for baseline measurement and between the ischemia–reperfusion and the ischemia–reperfusion+sufentanil groups at the 120th minutes measurement (p < 0.05).
CONCLUSION: Intrathecal sufentanil appears to have a cardioprotective effect against myocardial ischemia--reperfusion injury in the experimental rabbit model (Tab. 1, Fig. 2, Ref. 19).
Keywords: intrathecal sufentanil, preconditioning, myocardial ischemia–reperfusion, infarct size, hemodynamic changes
Published online: 09-Apr-2018
Year: 2018, Volume: 119, Issue: 4 Page From: 240, Page To: 244
doi:10.4149/BLL_2018_045


download file


© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.